Market cap
₹8 Cr
Revenue (TTM)
₹26 Cr
P/E Ratio
20.6
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
5.2 %
-
ROCE
5.8 %
-
Industry P/E
48.85
-
EV/EBITDA
4.3
-
Debt to Equity
0
-
Book Value
₹--
-
EPS
₹1
-
Face value
10
-
Shares outstanding
4,098,400
10 Years Aggregate
CFO
₹11.43 Cr
EBITDA
₹9.24 Cr
Net Profit
₹1.53 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dhanvantri Jeevan
| -19.7 | -15.4 | -10.7 | -2.6 | 16.4 | 25.5 | -4.9 |
|
BSE Healthcare*
| 9.1 | 1.2 | 7.9 | 7.7 | 25.1 | 13.2 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Dhanvantri Jeevan
| 17.8 | 63.9 | 2.3 | 4.7 | 149.8 | -40.9 | -53.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dhanvantri Jeevan
|
20.1 | 8.2 | 25.9 | 0.4 | 0.3 | 3.8 | 20.6 | 0.8 |
| 262.6 | 4,169.0 | 1,081.2 | 103.7 | 13.0 | 11.7 | 40.2 | 4.8 | |
| 815.0 | 42,224.3 | 4,643.2 | 464.1 | 13.7 | 8.9 | 108.8 | 9.2 | |
| 439.8 | 13,950.4 | 2,080.1 | 168.1 | 14.1 | 6.7 | 104.7 | 6.9 | |
| 630.5 | 9,417.2 | 2,545.4 | 21.3 | 8.7 | 11.4 | 684.4 | 7.1 | |
| 384.5 | 3,525.3 | 1,482.5 | 183.6 | 15.1 | 26.3 | 19.2 | 4.8 | |
| 1,315.7 | 8,630.8 | 1,494.5 | 194.1 | 17.1 | 13.2 | 44.5 | 5.6 | |
| 5,811.0 | 6,349.9 | 1,586.5 | 240.8 | 20.8 | 19.2 | 26 | 4.8 | |
| 1,365.0 | 13,849.1 | 1,703.1 | 281.5 | 23.1 | 17.7 | 49.8 | 8.4 | |
| 839.8 | 8,090.9 | 1,199.2 | 171.1 | 16.3 | 10.2 | 46.1 | 4.5 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsInvestor Protection Fund now owns 0.51% in RIL
2 min read•By Danish Khanna
About Dhanvantri Jeevan
Dhanvantri Jeevan Rekha Limited provides medical and health care services in India. The company operates the multi-specialty Dhanvantri hospital in Meerut. Its Dhanvantri Hospital offers diagnostic and therapeutic services, including cardiology,... neurology, respiratory medicine, gastroenterology, gastro surgery, neuro surgery, orthopedic surgery, urology, oral and maxillofaccial surgery, oncology, otorhinolaryngology, pathology, rehabilitation program, and other diagnostic services. The company also operates intensive coronary care units and intensive care units. In addition, it offers services for various breast problems, such as mastalgias, mastopathies, breast lumps, and breast cancer, as well as screening for early breast cancers and training for self-examinations. Dhanvantri Jeevan Rekha Limited was founded in 1993 and is based in Meerut, India. Read more
-
Incorporated
1993
-
Chairman
--
-
Managing Director
Shalini Sharma
-
Headquarters
Meerut, Uttar Pradesh
-
Website
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Dhanvantri Jeevan
What is the current share price of Dhanvantri Jeevan Rekha Ltd Today?
The share price of Dhanvantri Jeevan Rekha Ltd is ₹20.10 (BSE) as of 11-Jun-2026 IST. Dhanvantri Jeevan Rekha Ltd has given a return of 16.38% in the last 3 years.
What is the current PB & PE ratio of Dhanvantri Jeevan Rekha Ltd?
The P/E ratio of Dhanvantri Jeevan Rekha Ltd is 20.59 times as on 11-Jun-2026, a 58 discount to its peers’ median range of 48.85 times.
The P/B ratio of Dhanvantri Jeevan Rekha Ltd is 0.79 times as on 11-Jun-2026, a 89 discount to its peers’ median range of 7.07 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
16.73
|
0.84
|
|
2024
|
60.76
|
1.07
|
|
2023
|
0.00
|
0.58
|
|
2022
|
13.96
|
0.72
|
|
2021
|
0.00
|
0.34
|
What is the 52 Week High and Low of Dhanvantri Jeevan Rekha Ltd?
The 52-week high and low of Dhanvantri Jeevan Rekha Ltd are Rs 35.86 and Rs 19.00 as of 13-Jun-2026.
What is the market cap of Dhanvantri Jeevan Rekha Ltd?
Dhanvantri Jeevan Rekha Ltd has a market capitalisation of ₹ 8 Cr as on 11-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Dhanvantri Jeevan Rekha Ltd?
Before investing in Dhanvantri Jeevan Rekha Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
